Back to Agenda
Innovation Reimagined: How Intelligent Automation is Redefining Research and Development Excellence
Session Chair(s)
Venkatraman Balasubramanian, PhD, MBA
Healthcare and Life Sciences Strategic Advisor
VB Insights, LLC, United States
This session will explore how Intelligent Automation (IA) and AI are transforming R&D and Regulatory Affairs by automating document-heavy processes and driving data-driven decisions. Through real-world use cases presented by industry sponsors, attendees will learn how IA and AI are being applied to improve efficiencies, reduce timelines, and optimize regulatory outcomes.
Learning Objective : Understand AI applications in drug discovery, clinical trials, regulatory, manufacturing, and pharmacovigilance; Explore practical use cases of AI in Regulatory Operations; Discuss advancing fit-for-purpose, risk-based frameworks for AI and global regulatory alignment.
Speaker(s)
AI: Accelerating Clinical Trials Through Smarter Site Selection
Kevin Bugin, PhD, MS, RAC
Amgen, United States
Head of Global Regulatory Policy and Intelligence
Harnessing AI and Automation in Regulatory: Insights from the Recent DIA RIM Intelligent Automation Survey
Cary Smithson, MBA
LeapAhead Solutions, Inc., United States
Managing Partner
Industry Perspective
Cedric Berger, PhD, MBA
F. Hoffmann-La Roche, Switzerland
Head of Knowledge Extraction and Integration
AI-Driven Drug Development: Transforming Life Sciences with Data and Innovation
Sridevi Nagarajan, PhD, MS, MSc
Independent, United Kingdom
DIA Communities Lead for AI in Healthcare
Have an account?